Abstract -Thalassemia, a hematologic disorder characterized by the deficiency or the absence of -globin production, is the most widespread inherited disorder in the world; it is also common in Taiwan. We studied 38 patients in central Taiwan with -thalassemia major, using amplified created restriction site analysis for detection. On analysis, six different point mutations were found among 76 chromosomes, of which 32 chromosomes (42.1%) had a C to T substitution at nucleotide 654, 30 (40%) had frameshift codons 41/42 with four nucleotides (TCTT) deletion, 7 (9.2%) had an A to T substitution at codon 17, 3 (3.9%) had frameshift codons 71/72 (insertion of A), 2 (2.6%) had an A to G substitution at position Ϫ28, and 2 (2.6%) had frameshift codons 27/28 (insertion of C). The first two mutations accounted for 62 of the 76 -thalassemia mutations in this study. As to mutations in each individual with -thalassemia major, the incidence of compound heterozygotes of two different mutations was higher than that of homozygotes of a single mutation (60% vs 40%). Compound heterozygotes of C to T substitution at nucleotide 654 of IVS-2 and frameshift codons 41/42 with four-nucleotide deletion was the most common pattern of -thalassemia mutations in each individual (23.7%). Our results were unique compared with those from similar studies performed in southern China. Frequencies of -thalassemia mutations found in the current study were assessed and compared with frequencies found in previous studies conducted in northern and southern Taiwan.
Introduction
-Thalassemia is common in peoples of the Mediterranean region, Middle East, Southeast Asia, and southern China (Weatherall et al. 1981) . Worldwide, 216 known mutations are currently documented in the -globin gene. The disease is common in Taiwan, which is located about 100 miles off the southeast coast of mainland China, and has a population of about 21 million. The people of Taiwan consist of four main ethnic populations: Min-Nan (12,521,000), Hakka (5,411,000), Mainlander (3,229,000), and Aborigine (369,000). The carrier frequency of -thalassemia is estimated to be between 1% and 3% (Ko et al. 1989 ). The mutations of -thalassemia in northern and southern Taiwan have been extensively studied by Xu et al. (1990) , Lin et al. (1991 Lin et al. ( , 1992 , Chang et al. (1992) , and Chiou et al. (1993) . We reviewed and analyzed the eight most common mutations for this study, whose purpose was to determine the different mutations of the -globin gene in 38 patients with -thalassemia major and to review the patients' different clinical characteristics. Results were assessed and compared with those from similar studies in order to better understand those mutation characteristics that could be useful in genetic counseling and prenatal diagnosis programs for -thalassemia patients in Taiwan. These patients were first diagnosed using hemoglobin analysis. Mutations of the -globin gene were detected by amplified created restriction site (ACRS) analysis.
Subjects and methods

Subjects
A total of 38 patients with -thalassemia major from China Medical College Hospital were studied. All patients (age, 2-25 years) came from the central Taiwan area (Fig. 1) and were diagnosed by hemoglobin electrophoresis. The birthplaces and ethnic backgrounds of all 76 parents were recorded (Min-Nan, 52; Hakka, 19; Mainlander, 5). All patients required regular transfusions to maintain a hemoglobin level greater than 8 g/dl. Brief clinical data, including day of initial transfusion, hemoglobin (Hb) value, HbF, HbA 1 , and HbA 2 were measured for each patient.
ACRS analysis of -thalassemia
The genomic DNA was extracted from the buffy coat cells of 8-10 ml of heparinized peripheral blood of the patients and their parents with a DNA Extractor WB Kit (Wako, Tokyo, Japan). -Thalassemia mutations were directly detected by the method of naturally and amplified created restriction sites, as previously described (Chang et al. 1992) . Table 1 shows the sequences of primers, the natural or created enzyme restriction sites, and the resulting fragment sizes after digestion.
Amplification conditions were as follows. Briefly, 0.1 µg of genomic DNA was mixed with 100 ng of each primer and 200 µm of each dNTP in 100µl reaction buffer containing 10 mM Tris-HCl (pH 8.3), 50mM KCl, 15 mM MgCl 2 , and 0.01% gelatin. The mixture was incubated at 94°C for 2 min for strand separation and then 5 units of Taq polymerase were added. Thirty-five cycles of denaturation at 94°C for 2 min, annealing at 55°C for 2 min, and extension at 72°C for 3 min were performed by a Perkin-Elmer DNA Thermal Cycler (Foster City, CA, USA) (Wong et al. 1987) .
Results
Detection of mutation by ACRS Table 2 shows the results of -thalassemia mutation detection in different ethnic groups in central Taiwan and a comparison of the relative frequencies of nine common mutations in different areas of Taiwan. Six of the nine mutations were found in our 38 study patients. The pattern of mutations showed a similar trend based on the three major ethnic groups in central Taiwan (Min-Nan, Hakka, and Mainlanders), but no Aborigines were among the current study population. All patients with -thalassemia major were found to have mutations in both -globin alleles, either homozygous or compound heterozygous. These mutations have been observed before in patients in northern and southern Taiwan ( Table 2 ). Three of the six mutations in our study, listed in Table 2 including the C to T transition at nucleotide 654 of IVS-2, the four-nucleotide deletion at codons 41/42, and the A to T transversion at codon 17, account for the great majority (91.3%) of our detectedthalassemia mutation alleles. The most common mutation, accounting for 42.1% of -thalassemia mutation alleles in our study, was the C to T transition at nucleotide 654 of IVS-2, followed by the four-nucleotide deletion at codons 41/42 (40%), A to T transversion at codon 17 (9.2%), frameshift codons 71/72 (insertion of A) (3.9%), A to G transversion at position Ϫ28 of promoter region (2.6%), and frameshift codons 27/28 (insertion of C) (2.6%). Mutant alleles of the G to T transversion at nucleotide 1 of IVS-1 and IVS-1 3Ј end TAG → GAG, reported in other -thalassemia mutation studies in northern and southern Taiwan, were not detected in this study (Table 2 ). Other mutations, such as those in promoter area: Ϫ29 and Ϫ30, initiation codon mutation, IVS-1 nucleotide 5 mutation, codon 43 nonsense mutation, and codons 14/15 frameshift mutation, were not found in our study. As to mutation patterns in each individual, the incidence of compound heterozygotes of two differet mutations was higher than the incidence of homozygotes of a single mutation (60% vs 40%). The compound heterozygosity of the C to T substitution at nucleotide 654 of IVS-2 and codons 41/42 frameshift were the most common (23.7%) pattern of mutation detected in patients with -thalassemia major in central Taiwan (Table 3) .
Clinical, hematological and Hb composition data All 38 patients are transfusion-dependent and are currently being treated with deferoxamine mesylate (Desferal; Novartis, Switzerland). Table 3 lists the hematological data for all patients with specific nucleotide substitutions, with the mean levels of HbA 2 , HbF, and HbA 1 . On comparing these data we found no significant differences among the individual genotypes. All patients needed early initial redcell transfusions before or around 1 year of age, except for one patient with homozygotes of a single mutation at nucleotide 654 of IVS-2, who did not receive an initial transfusion until 8.5 years of age. (Based on our three patients who also showed the α-thalassemia trait, there were no apparent differences between them and the other -thalassemia patients in terms of clinical manifestations.)
Discussion
In general, each population tends to have different or some specific mutation alleles in the -globin gene, including some that are very common and others that are rare (Kazazian 1990; Bunn et al. 1986 ). In southern China, the distribution of mutations in the -globin gene differs even within the three neighboring provinces of Guangdong, Guangxi, and Sichuan (Liu et al. 1989 ). This may be due to the large number of ethnic groups in this area. Taiwanese have close ethnic ties to people in mainland China. The mutation spectrum of -thalassemia among the mixture of populations in Taiwan was well established by Chang et al. (1992) . In our study, the mutations ofthalassemia in central Taiwan are similar to findings in previous reports of the mutations in northern and southern Taiwan (Table 2 ), but are unique compared to findings reported in southern China. Current data regarding specific mutations of -globin genes in southern China can be traced Values are means Ϯ SD, except where SD not shown * a Each genotype includes one patient who also had the α-thalassemia trait *b One patient's first transfusion at age 8.5 years to patients from Guangdong province (Lam et al. 1990 ). Frameshift codons 41/42 (Ϫ4 nucleotides deletion) were reported to be the most common mutation (Orkin et al. 1983; Kimura et al. 1983; Cheng et al. 1984; Kazazian et al. 1986; Chan et al. 1987 Chan et al. , 1988 Antonarakis et al. 1988; Zhang et al. 1988; Huang et al. 1988) . However, in our study, the allele frequency of the C to T substitution at nucleotide 654 of IVS-2 and frameshift codons 41/42 (ϪTCTT) are similar and are two of the most common mutations found in central Taiwan, followed by the codon 17 (A → T) mutation. The incidence of the nonsense codon 17 mutation in Guangxi and Sichuan provinces of mainland China is higher than the incidence of the IVS-2 nucleotide 654 and Ϫ28 mutations, but this characteristic is not shown in Guangdong province or in regions in northern and southern Taiwan, according to Liu et al. (1989) and our results. The A to G substitution at position Ϫ29 in the promoter area is rare in Sichuan province and even rarer in Guangdong and Guangxi provinces and central Taiwan. These results may be linked to area and population variations. Our results are compatible with those of Chang et al. (1990) concerning the mutations of -thalassemia minor in northern Taiwan and the C to T substitution at nucleotide 654 of IVS-2, which is still the most common type of mutation in -thalassemia major. As to mutations within different populations of Taiwan, the spectra are similar in the Min-Nan and Hakka populations. Although many Hakka have roots in Guangdong province, their mutations may be closer to those in Min-Nan people than to those in people from in Guangdong. Our results are also similar to those concerning the mutations of -thalassemia in northern and southern Taiwan (Lin et al. 1991; Chiou et al. 1993) . Frameshift codons 27/28 (insertion of C), which cause a premature termination of translation at the new codon 59, have been reported in two Hakka-Taiwanese and a patient from Guangdong province (Lin et al. 1991; Cai et al. 1991) . Since this novel mutation was also detected in a Min-Nan patient in our study, it suggests that this mutation is not rare in the Chinese. This mutation decreases normal RNA splicing and has also been found in a Saudi-Arabian patient (Wong et al. 1989) . Mutation of IVS-1 nucleotide 1 (G-T) is a common mutation in Indians, but is rare in Chinese, probably due to the migration of this mutant -globin allele from India to China (Varamalla et al. 1991; Kazazian et al. 1986 ). The patients in our study were subdivided according to whether they were either homozygotes or compound heterozygotes to characterize any differences between genotypes and clinical manifestations. Table 3 shows that all patients with homozygotes or compound heterozygotes of -thalassemia mutation are likely to have Cooley's phenotype (WHO Working Group 1982) and needed early initial packed red cell transfusion before or around 1 year of age, except for one patient with homozygotes of nucleotide 654 of IVS-2, who did not receive an initial transfusion until 8.5 years of age. The reason for this long period is unclear and requires further investigation.
These characterization of mutations could be useful for genetic counseling, evaluation of clinical manifestations, and determining prenatal diagnosis programs forthalassemia patients in central Taiwan.
The data shown in Table 2 indicate the importance of identifying various mutations in a given population of Taiwan. The information is very useful for physicians when they are planning specific therapeutic approaches, for genetic counselors to educate young couples and families, and for scientists to understand the mutation's effect as expressed in a gene. It is equally important to establish prenatal diagnosis centers in order to reduce long-term health costs and channel resources to those areas where they can be used for the better management of affected individuals.
